share_log

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Sakiris Spiro Kevin

SEC announcement ·  Mar 22 07:57
Summary by Futu AI
Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.
Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.